• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多发性骨髓瘤表现为 68Ga-替奈普酶 PET/CT 超级扫描。

Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.

出版信息

Clin Nucl Med. 2018 Jun;43(6):462-463. doi: 10.1097/RLU.0000000000002067.

DOI:10.1097/RLU.0000000000002067
PMID:29538035
Abstract

A 60-year-old woman diagnosed with multiple myeloma was referred for Ga-pentixafor PET/CT for evaluation of the disease. Diffuse and intense radioactivity throughout the axial and proximal appendicular skeleton was noted on PET/CT images, suggestive of extensive involvement of multiple myeloma.

摘要

一位 60 岁女性被诊断为多发性骨髓瘤，因该疾病行 Ga- 戊乙奎醚 PET/CT 检查。PET/CT 图像显示，整个轴骨和近侧附肢骨骼弥漫性和强烈放射性摄取，提示多发性骨髓瘤广泛受累。

相似文献

1
Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.多发性骨髓瘤表现为 68Ga-替奈普酶 PET/CT 超级扫描。
Clin Nucl Med. 2018 Jun;43(6):462-463. doi: 10.1097/RLU.0000000000002067.
2
Pulmonary Cryptococcosis Accidentally Detected by 68Ga-Pentixafor PET/CT in a Patient With Multiple Myeloma.68Ga- 五肽受体 PET/CT 意外发现多发性骨髓瘤患者肺部隐球菌病。
Clin Nucl Med. 2020 May;45(5):423-425. doi: 10.1097/RLU.0000000000003004.
3
Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.用 68Ga-培他索仑（pentixafor）进行趋化因子受体 CXCR4 靶向 PET/CT 检查在一名华氏巨球蛋白血症患者中的表现优于 18F-FDG。
Clin Nucl Med. 2018 Jul;43(7):548-550. doi: 10.1097/RLU.0000000000002131.
4
Increased Uptake of 68Ga-Pentixafor in Thymic Rebound After Chemotherapy in a Patient With Multiple Myeloma.化疗后胸苷酸合成酶在多发性骨髓瘤患者胸腺反弹中摄取增加。
Clin Nucl Med. 2021 Jan;46(1):90-92. doi: 10.1097/RLU.0000000000003375.
5
Chemokine Receptor 4-Targeted PET/CT With 68 Ga-Pentixather Detects More Lesions Than 68 Ga-Pentixafor PET/CT in Multiple Myeloma.靶向趋化因子受体 4 的 68Ga-戊替他肽 PET/CT 比 68Ga-戊昔妥昔肽 PET/CT 检测多发性骨髓瘤的病灶更多。
Clin Nucl Med. 2024 Jun 1;49(6):592-593. doi: 10.1097/RLU.0000000000005194. Epub 2024 Apr 17.
6
[Ga]Pentixafor PET/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [F]FDG PET/CT.[镓]喷替沙福PET/CT用于新诊断多发性骨髓瘤的分期和预后评估：与[氟]氟代脱氧葡萄糖PET/CT的比较
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):1926-1936. doi: 10.1007/s00259-024-06621-0. Epub 2024 Jan 30.
7
Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.采用 68Ga-环五聚蛋白 PET/CT 成像技术检测蕈样肉芽肿中趋化因子受体 CXCR4
Clin Nucl Med. 2018 Aug;43(8):606-608. doi: 10.1097/RLU.0000000000002166.
8
Chemokine receptor-4 targeted PET/CT with Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to F-FDG PET/CT.使用镓标记的喷替沙氟进行趋化因子受体-4靶向PET/CT在新诊断多发性骨髓瘤评估中的应用：与氟代脱氧葡萄糖PET/CT的比较
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):537-546. doi: 10.1007/s00259-019-04605-z. Epub 2019 Nov 27.
9
[Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [F]FDG and laboratory values.[镓]喷替沙福-PET/CT用于多发性骨髓瘤中趋化因子受体CXCR4表达的成像——与[氟]氟代脱氧葡萄糖及实验室检查值的比较
Theranostics. 2017 Jan 1;7(1):205-212. doi: 10.7150/thno.16576. eCollection 2017.
10
68Ga-Pentixafor PET/CT Improves the Detection of Recurrent Myeloma in the Temporal Bone Masked by the Physiological 18F-FDG Uptake of the Brain and Extraocular Muscles.68Ga- 培哚普利托 PET/CT 提高了因脑和眼外肌生理性 18F-FDG 摄取而被掩盖的颞骨复发性骨髓瘤的检出率。
Clin Nucl Med. 2022 Apr 1;47(4):e348-e350. doi: 10.1097/RLU.0000000000003979.

引用本文的文献

1
Reduced splenic uptake of [Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma.一线化疗后[镓]镓-喷替沙氟脾摄取降低与新诊断的多发性骨髓瘤患者预后不良相关。
EJNMMI Res. 2025 Jun 20;15(1):74. doi: 10.1186/s13550-025-01262-2.
2
Targeting the chemokine receptor CXCR4 for cancer therapies.以趋化因子受体CXCR4为靶点进行癌症治疗。
Biomark Res. 2025 May 1;13(1):68. doi: 10.1186/s40364-025-00778-y.
3
Superscan Pattern on Bone Scintigraphy: A Comprehensive Review.
骨闪烁显像中的超级骨显像模式：综述
Diagnostics (Basel). 2024 Oct 6;14(19):2229. doi: 10.3390/diagnostics14192229.
4
CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors.CXCR4 靶向放射性药物在恶性肿瘤的成像和治疗中的应用。
Molecules. 2023 Jun 12;28(12):4707. doi: 10.3390/molecules28124707.
5
Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease.镓-喷替沙氟正电子发射断层扫描/计算机断层扫描（Ga-Pentixafor PET/CT）可能无法检测出伴有髓外病变的复发性多发性骨髓瘤。
Diagnostics (Basel). 2023 Feb 24;13(5):871. doi: 10.3390/diagnostics13050871.
6
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [Ga]pentixafor in non-Hodgkin lymphoma: comparison to [F]FDG.[镓]喷替沙氟靶向PET/CT对趋化因子受体-4在非霍奇金淋巴瘤中的成像初步证据：与[氟]氟代脱氧葡萄糖的比较
EJNMMI Res. 2020 Aug 5;10(1):89. doi: 10.1186/s13550-020-00681-7.
7
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.多发性骨髓瘤的治疗评估和微小残留病灶检测的功能成像。
Int J Mol Sci. 2020 Jul 29;21(15):5406. doi: 10.3390/ijms21155406.
8
Fully-automated production of [Ga]Ga-PentixaFor on the module Modular Lab-PharmTracer.在模块化实验室-药物示踪剂模块上全自动生产[镓]镓-喷替酸五乙酸。
EJNMMI Radiopharm Chem. 2020 Feb 27;5(1):8. doi: 10.1186/s41181-020-0091-2.
9
Chemokine receptor-4 targeted PET/CT with Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to F-FDG PET/CT.使用镓标记的喷替沙氟进行趋化因子受体-4靶向PET/CT在新诊断多发性骨髓瘤评估中的应用：与氟代脱氧葡萄糖PET/CT的比较
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):537-546. doi: 10.1007/s00259-019-04605-z. Epub 2019 Nov 27.
10
C-terminal-modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4.C 端修饰的 LY2510924：靶向 C-X-C 趋化因子受体 4 的多功能支架。
Sci Rep. 2019 Oct 25;9(1):15284. doi: 10.1038/s41598-019-51754-0.